ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	15/131	134/7206	1.52909014131e-08
ko04668	TNF signaling pathway	13/131	120/7206	2.18485047142e-07
ko05164	Influenza A	15/131	167/7206	2.95346114942e-07
ko04060	Cytokine-cytokine receptor interaction	16/131	191/7206	3.02831136947e-07
ko04621	NOD-like receptor signaling pathway	12/131	157/7206	2.54636284437e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	13/131	191/7206	3.97196006612e-05
ko04620	Toll-like receptor signaling pathway	9/131	100/7206	7.74894487997e-05
ko04660	T cell receptor signaling pathway	10/131	124/7206	7.87500830049e-05
ko04210	Apoptosis	12/131	180/7206	9.74389832154e-05
ko05160	Hepatitis C	11/131	153/7206	9.80357792951e-05
ko04630	Jak-STAT signaling pathway	10/131	132/7206	0.000133187126777
ko05161	Hepatitis B	11/131	173/7206	0.000290680795756
ko05162	Measles	9/131	120/7206	0.000313742939132
ko04064	NF-kappa B signaling pathway	8/131	96/7206	0.000333761781067
ko04623	Cytosolic DNA-sensing pathway	5/131	41/7206	0.000815288982227
ko00051	Fructose and mannose metabolism	5/131	42/7206	0.000912129483186
ko04657	IL-17 signaling pathway	7/131	87/7206	0.000976119906482
ko04662	B cell receptor signaling pathway	7/131	88/7206	0.00104468836721
ko04217	Necroptosis	10/131	178/7206	0.00143387529646
ko05168	Herpes simplex infection	10/131	182/7206	0.00169408110479
ko04932	Non-alcoholic fatty liver disease (NAFLD)	10/131	182/7206	0.00169408110479
ko05132	Salmonella infection	7/131	98/7206	0.00195982536538
ko05142	Chagas disease (American trypanosomiasis)	8/131	130/7206	0.00244307618881
ko04931	Insulin resistance	8/131	137/7206	0.00338242989005
ko04062	Chemokine signaling pathway	10/131	201/7206	0.00350338575371
ko05131	Shigellosis	6/131	82/7206	0.00364310304029
ko04672	Intestinal immune network for IgA production	4/131	37/7206	0.00432983068037
ko04917	Prolactin signaling pathway	6/131	87/7206	0.00488123088137
ko04622	RIG-I-like receptor signaling pathway	5/131	62/7206	0.00519655486111
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/131	92/7206	0.00640448023537
ko05145	Toxoplasmosis	7/131	126/7206	0.00787576925874
ko05134	Legionellosis	5/131	74/7206	0.010888183467
ko04933	AGE-RAGE signaling pathway in diabetic complications	7/131	135/7206	0.0112965506447
ko01524	Platinum drug resistance	5/131	76/7206	0.0121348829101
ko05418	Fluid shear stress and atherosclerosis	8/131	173/7206	0.0132978984237
ko05215	Prostate cancer	6/131	111/7206	0.0153993821373
ko05230	Central carbon metabolism in cancer	5/131	81/7206	0.0156679656265
ko04930	Type II diabetes mellitus	4/131	54/7206	0.0163698700923
ko05152	Tuberculosis	8/131	187/7206	0.0203492647752
ko05133	Pertussis	5/131	87/7206	0.0207420590802
ko05166	HTLV-I infection	11/131	292/7206	0.0211755787878
ko05323	Rheumatoid arthritis	5/131	89/7206	0.0226464684251
ko04920	Adipocytokine signaling pathway	5/131	89/7206	0.0226464684251
ko04211	Longevity regulating pathway	6/131	123/7206	0.0242672431935
ko04722	Neurotrophin signaling pathway	7/131	160/7206	0.026283641958
ko05221	Acute myeloid leukemia	4/131	63/7206	0.0272341700522
ko04658	Th1 and Th2 cell differentiation	5/131	96/7206	0.0301919685968
ko04650	Natural killer cell mediated cytotoxicity	5/131	97/7206	0.0313845920423
ko04068	FoxO signaling pathway	7/131	167/7206	0.0321759160294
ko04080	Neuroactive ligand-receptor interaction	2/131	423/7206	0.0357118707573
ko05140	Leishmaniasis	4/131	75/7206	0.0471479581746